RIP2 kinase inhibitor 1 (compound 11) is a potent and selective receptor interacting protein 2 (RIP2) kinase inhibitor with an IC50 of 0.03 μM for RIP2 FP. RIP2 kinase inhibitor 1 is used for autoinflammatory disorders.

Product information

CAS Number: 2380028-10-2

Molecular Weight: 355.41

Formula: C17H17N5O2S

Chemical Name: (1S, 9R, 11S)-5-(1, 3-benzothiazol-5-yl)-11-hydroxy-2, 6, 7-triazatricyclo[7.2.1.0, ]dodeca-3, 5-diene-4-carboxamide

Smiles: NC(=O)C1C(=NN2C[C@H]3C[C@H](O)[C@H](C3)NC2=1)C1=CC=C2SC=NC2=C1

InChiKey: IYLHBITVRJLWLH-QRTLGDNMSA-N

InChi: InChI=1S/C17H17N5O2S/c18-16(24)14-15(9-1-2-13-11(5-9)19-7-25-13)21-22-6-8-3-10(12(23)4-8)20-17(14)22/h1-2,5,7-8,10,12,20,23H,3-4,6H2,(H2,18,24)/t8-,10+,12+/m1/s1

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vitro:

RIP2 kinase inhibitor 1 (compound 11) inhibits human whole blood (hWB; IC50=0.05 μM), activin receptor-like kinase 5 (ALK5; IC50>10 μM), VEGFR2 (IC50=7.94 μM), lymphocyte-specific protein tyrosine kinase (LCK; IC50=31.6 μM).

Products are for research use only. Not for human use.